TaskUs price target lowered to $12 from $13 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on TaskUs to $12 from $13 and keeps an Equal Weight rating on the shares. While better-than-expected seasonal volumes and recent healthcare signings encouraged management to raise its calendar 2023 revenue outlook, the firm expects flat calendar 2024 revenue growth, offset by 23.5% adjusted EBIDTA margins, the analyst tells investors in a post-earnings note.